Regeneron Pharmaceuticals (REGN) 422.13 $REGN 3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Regeneron Pharmaceuticals (REGN) 422.13 $REGN

3 Little-Known Stocks I'm Glad I Bought
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 08, 12:04PM CDT
Source: Flickr user stockmonkeys.com. Investing in clinical-stage biotech stocks isn't for the faint of heart. The industry's jaw-dropping pops and drops can be so dramatic as to suit these stocks only the most speculative portion of an investor's...
JNJ: 100.11 (-2.41), INSY: 57.69 (+0.08), PTLA: 41.72 (-0.13), PFE: 33.97 (-0.50), OPHT: 53.19 (-0.29), BMY: 65.12 (-0.93), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

Complexities Of Eye Care Drive Strong Moats
Morningstar - at Seeking Alpha - Fri Mar 06, 4:10PM CST
By David Krempa, CFA We see attractive growth opportunities for the ophthalmology market. We see strong competitive advantages in the $50 billion ophthalmology market as a result of manufacturing complexity, strict government regulation, limited...
AGN: 233.51 (-1.90), ABT: 46.50 (-0.94), JNJ: 100.11 (-2.41), VRX: 198.71 (-5.24), AKRX: 49.83 (-1.05), LUX: 60.94 (-0.30), COO: 180.26 (+15.00), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

Regeneron Jumps Ahead In $10 Billion Race For Next Generation Cardio Drugs
Cheryl Swanson - at Seeking Alpha - Fri Mar 06, 1:35PM CST

PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)

Market Is Looking For Positive News - Cramer's Mad Money (3/4/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Mar 05, 6:45AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, March 4. The market closed lower on Wednesday, but Cramer still thinks the market and stocks will go higher on any positive news. Citing Wayfair's (NYSE: W )...
HYH: 46.26 (+0.79), RH: 89.94 (-0.65), GPRO: 40.13 (-0.95), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PCYC: 254.56 (+0.34), KMB: 106.82 (-1.64), LLTC: 47.65 (-0.72), BMY: 65.12 (-0.93), ALKS: 68.19 (-3.03), CHRS: 27.48 (-2.23), CELG: 118.03 (-2.68), W: 28.81 (+1.03), ISIS: 70.44 (-1.32), GILD: 101.81 (-1.61), LH: 121.70 (-1.58), MCD: 97.13 (-1.98), REGN: 422.13 (-6.82), BABA: 84.40 (-1.70)

Must-See Charts: How to Trade 5 Big Stocks for Big Gains
at The Street - Thu Mar 05, 6:00AM CST
Here's a technical look at how to trade some of the biggest stocks on Wall Street.
MDLZ: 35.22 (-1.29), GIS: 52.13 (-1.15), REGN: 422.13 (-6.82), SYK: 90.07 (-2.92), EQR: 75.03 (-2.30)

Jim Cramer's Top Takeaways: Wayfair, Honeywell, Halyard Health, More
at The Street - Thu Mar 05, 4:34AM CST
Cramer says that Honeywell is his one of his favorite industrial stocks and that the biotech sector is filled with strong buys, including Regeneron and Celgene.
HYH: 46.26 (+0.79), RH: 89.94 (-0.65), BIIB: 417.63 (-7.98), W: 28.81 (+1.03), HON: 101.87 (-1.26), GILD: 101.81 (-1.61), KMB: 106.82 (-1.64), RRD: 19.48 (+0.21), REGN: 422.13 (-6.82), CELG: 118.03 (-2.68)

Jim Cramer's 'Mad Money' Recap: The Market Is a Battlefield
at The Street - Wed Mar 04, 7:14PM CST
Investors have to pay attention to see what's really worth buying.
RH: 89.94 (-0.65), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PCYC: 254.56 (+0.34), HON: 101.87 (-1.26), KMB: 106.82 (-1.64), RRD: 19.48 (+0.21), JNJ: 100.11 (-2.41), W: 28.81 (+1.03), SCTY: 50.45 (-1.32), CMG: 658.68 (-11.81), RCPT: 140.09 (-1.10), FL: 59.37 (+2.34), REGN: 422.13 (-6.82), HYH: 46.26 (+0.79), CY: 15.10 (-0.40), SWKS: 90.75 (-0.80), VFC: 74.49 (-1.58), NXPI: 98.48 (-0.19), ALKS: 68.19 (-3.03), CELG: 118.03 (-2.68), WWAV: 41.79 (-0.63), URBN: 38.89 (+0.15), HAIN: 61.66 (-1.03), FSLR: 60.61 (-1.05), GOGO: 20.21 (+0.14), ISIS: 70.44 (-1.32), GILD: 101.81 (-1.61), MCD: 97.13 (-1.98), STM: 9.18 (-0.13), DST: 106.03 (+0.16), BIG: 48.52 (+0.70), AVGO: 127.89 (-2.68)

Novartis Sees Past Lucentis's Decline
EP Vantage - Seeking Alpha - Wed Mar 04, 9:21AM CST
Having been outmanoeuvred first on price and then on dosing, Novartis (NYSE: NVS ) is preparing its next line of defence in macular degeneration as sales of its flagship Lucentis plateau. A phase II trial has shown that RTH258 is the equal of ...
REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

Sarcopenia Therapeutics Pipeline Review 2015 - 9 Companies & 12 Drug Profiles
M2 - Mon Mar 02, 8:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/tthlfw/sarcopenia) has announced the addition of the "Sarcopenia - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Sarcopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcopenia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Calzada Limited - Cytokinetics, Inc. - GlaxoSmithKline plc - Myos Corporation - Neurotune AG - Novartis AG - PsiOxus Therapeutics, Ltd. - Regeneron Pharmaceuticals, Inc. - Sumitomo Dainippon Pharma Co., Ltd. Drug Profiles - AOD-9604 - bimagrumab - CK-2066260 - MT-102 - NEP-28 - NT-1654 - Protein for Musculoskeletal Disorders - Recombinant Protein for Sarcopenia - REGN-1033 - S-107 - Small Molecules to Inhibit Furin for Sarcopenia and Cachexia - Small Molecules to Inhibit JAK3 for Sarcopenia and Cachexia For more information visit http://www.researchandmarkets.com/research/tthlfw/sarcopenia
CYTK: 7.80 (-0.11), GSK: 46.73 (-0.87), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

A Quick Review Of The Asthma Market
Declan Fallon - at Seeking Alpha - Fri Feb 27, 9:26AM CST

PRGO: 156.83 (-3.17), AZN: 66.27 (-1.91), MRK: 56.84 (-1.14), AMGN: 154.88 (-4.72), TEVA: 56.40 (-0.11), IMNP: 1.73 (-0.03), THRX: 19.60 (-0.26), GSK: 46.73 (-0.87), XNCR: 15.33 (-0.67), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

Sanofi assumes all Zaltrap development from Regeneron
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:01AM CST

SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog
Arpita Dutt - Zacks Investment Research - Thu Feb 26, 10:07AM CST
Is Pharmacyclics (PCYC) up for sale? J&J and Novartis are rumored to be interested in acquiring the company.
VRTX: 126.34 (-0.62), PCYC: 254.56 (+0.34), VVUS: 2.79 (-0.08), AMGN: 154.88 (-4.72), ALKS: 68.19 (-3.03), REGN: 422.13 (-6.82), CELG: 118.03 (-2.68)

New indication for Regeneron's Eylea cleared in Europe
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 7:59AM CST

REGN: 422.13 (-6.82)

'Mad Money' Lightning Round: I Believe in Alcoa and Its CEO
at The Street - Thu Feb 26, 5:00AM CST
Cramer likes Spansion and Taiwan Semiconductor but isn't crazy about Theravance and SanDisk.
CY: 15.10 (-0.40), SWIR: 35.24 (-1.14), SWKS: 90.75 (-0.80), TSM: 24.09 (-0.37), CELG: 118.03 (-2.68), YHOO: 43.44 (-0.72), AA: 14.48 (+0.10), OPK: 14.11 (-0.21), THRX: 19.60 (-0.26), REGN: 422.13 (-6.82), SNDK: 80.65 (-1.86), BABA: 84.40 (-1.70), CODE: 36.99 (-0.98)

SanDisk Has Disappointed Twice - Cramer's Lightning Round (2/25/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 26, 4:51AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 25. Bullish Calls: Spansion (NYSE: CODE ): "I like Spansion because of the merger with Cypress Semiconductor (NASDAQ: CY ). I want you to...
SWIR: 35.24 (-1.14), CY: 15.10 (-0.40), BMRN: 113.77 (+0.27), SWKS: 90.75 (-0.80), TSM: 24.09 (-0.37), CELG: 118.03 (-2.68), YHOO: 43.44 (-0.72), AA: 14.48 (+0.10), OPK: 14.11 (-0.21), TBPH: 20.23 (-0.52), SNDK: 80.65 (-1.86), AVGO: 127.89 (-2.68), REGN: 422.13 (-6.82), CODE: 36.99 (-0.98), BABA: 84.40 (-1.70)

Jim Cramer's 'Mad Money' Recap: Kicking Out Value for Old-Fashioned Growth Stocks
at The Street - Wed Feb 25, 7:01PM CST
Investors have collectively decided that they're OK with a little more risk, Cramer says.
GE: 25.42 (-0.40), BX: 38.75 (-0.39), INTC: 33.19 (-0.54), LQ: 22.50 (-0.05), SBUX: 92.21 (-1.42), YHOO: 43.44 (-0.72), OPK: 14.11 (-0.21), CMG: 658.68 (-11.81), GOOGL: 572.90 (-8.53), LOW: 73.51 (-1.05), THRX: 19.60 (-0.26), MSFT: 42.36 (-0.75), REGN: 422.13 (-6.82), CODE: 36.99 (-0.98), KO: 41.52 (-0.88), SWIR: 35.24 (-1.14), CY: 15.10 (-0.40), AMZN: 380.09 (-7.74), HD: 114.45 (-1.46), FEYE: 42.83 (-1.08), SWKS: 90.75 (-0.80), FB: 80.00 (-1.21), TSM: 24.09 (-0.37), HPQ: 33.18 (-0.82), CELG: 118.03 (-2.68), NFLX: 454.12 (-13.53), AA: 14.48 (+0.10), TOL: 36.92 (-1.00), SNDK: 80.65 (-1.86), CRM: 64.56 (-1.03), BABA: 84.40 (-1.70)

Billions on the Line in the Next Drug Pricing War
Keith Speights, The Motley Fool - Motley Fool - Tue Feb 24, 7:02AM CST
Source: Gilead Sciences  One win whets the appetite for another. That certainly seems to be the case for the nation's two largest pharmacy benefits managers, Express Scripts and CVS Health . After scoring a victory in bringing hepatitis C...
ESRX: 82.27 (-2.01), GILD: 101.81 (-1.61), CVS: 101.90 (-1.46), REGN: 422.13 (-6.82)

Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 24, 6:40AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, February 23. With Nasdaq near all-time highs after 15 years, Cramer is listening to people talk about a new bubble forming. He said one of the good things about...
TSLA: 193.88 (-6.75), VRX: 198.71 (-5.24), CYBR: 59.78 (-3.09), AMGN: 154.88 (-4.72), INTC: 33.19 (-0.54), GOOG: 567.68 (-7.65), ORCL: 42.38 (-1.42), CELG: 118.03 (-2.68), AGEN: 5.11 (-0.17), T: 33.48 (-0.52), CTB: 37.05 (-0.43), JPM: 60.89 (-1.11), GILD: 101.81 (-1.61), HZNP: 21.91 (+1.07), GM: 36.84 (-0.77), GOOGL: 572.90 (-8.53), MSFT: 42.36 (-0.75), VZ: 48.29 (-0.63), DOW: 47.94 (-0.95), AAPL: 126.60 (+0.19), REGN: 422.13 (-6.82), CSCO: 28.92 (-0.38)

'Mad Money' Lightning Round: Buy Enbridge Energy Partners
at The Street - Tue Feb 24, 5:00AM CST
Cramer isn't excited by Yahoo!, would buy more Xcel Energy and likes Cisco over Arris Group.
XEL: 33.65 (-1.28), BCRX: 10.05 (-0.18), BX: 38.75 (-0.39), WFC: 54.59 (-0.25), EEP: 38.43 (-0.17), CELG: 118.03 (-2.68), YHOO: 43.44 (-0.72), APO: 22.28 (-0.42), ISIS: 70.44 (-1.32), JPM: 60.89 (-1.11), ARRS: 28.54 (-0.46), KATE: 32.82 (-0.44), CSCO: 28.92 (-0.38), REGN: 422.13 (-6.82)

Enbridge Energy Partners Is Cheap - Cramer's Lightning Round (2/23/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 24, 4:53AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, February 23. Bullish Calls: Enbridge Energy Partners (NYSE: EEP ): "I think this stock is way too cheap. I like the 5% yield. I think the management...
XEL: 33.65 (-1.28), BCRX: 10.05 (-0.18), BMRN: 113.77 (+0.27), BX: 38.75 (-0.39), KORS: 65.98 (-1.16), EEP: 38.43 (-0.17), CELG: 118.03 (-2.68), YHOO: 43.44 (-0.72), COH: 41.43 (-0.68), APO: 22.28 (-0.42), JPM: 60.89 (-1.11), ISIS: 70.44 (-1.32), ARRS: 28.54 (-0.46), KATE: 32.82 (-0.44), REGN: 422.13 (-6.82), CSCO: 28.92 (-0.38)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 130

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 50

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 75

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 99

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 50

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 49

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 142

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 81

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 54

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading

Top 5 Most Recently Viewed Articles

Stellus Capital Achieves Milestone with 52-Week High Stock Surge

Updated Category News Views 254

Stellus Capital Achieves 52-Week High Stock Performance Stellus Capital Investment Corporation (NYSE: SCM) has recently marked a noteworthy milestone, with its stock soaring to a remarkable 52-week high of $14.7. This significant rise demonstrates the company’s robust growth trajectory and strategic maneuvers in the financial market. Stellus Capital has effectively...

Continue Reading
Key Market Movements Amid Global Economic Developments

Updated Category News Views 276

An Overview of Current Market Dynamics As we delve into the latest market trends, the dollar has recently experienced a notable decline, marking its lowest point of the year. This downturn is primarily attributed to the Bank of Japan's long-anticipated interest rate hike, which has shifted investor sentiments across the globe. Concurrently, the euro zone has shown...

Continue Reading
Zain Bahrain Claims Top Award for Outstanding Customer Engagement

Updated Category News Views 207

Zain Bahrain Claims Best-Connected Customer Experience Award Zain Bahrain, a major player in the telecommunications field, has recently been honored with the prestigious award for Best-Connected Customer Experience from IST Networks and Genesys. This remarkable recognition, awarded during LEAP, celebrates Zain Bahrain's remarkable journey in enhancing customer engagement...

Continue Reading
Insurance Crisis in America: Florida and California Impacted

Updated Category News Views 250

Alarming Insurance Trends in Florida and California The insurance landscape in certain parts of the United States is undergoing drastic changes. Recent analyses depict a troubling picture for homeowners in Florida and California, where reports show that a significant number of policyholders are being dropped by their insurance companies at an unprecedented rate. Florida...

Continue Reading
Axis Capital Achieves Record Stock High at $88.45

Updated Category News Views 134

Axis Capital's Remarkable Stock Performance In a stunning display of financial strength, Axis Capital Holdings Limited (NYSE: AXS) has achieved a groundbreaking stock price of $88.45, marking a historic milestone for the company. This surge reflects the robust growth that AXS has experienced over the past year, with a remarkable 59.47% increase noted in its stock...

Continue Reading